Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial
- PMID: 19147639
- PMCID: PMC2628297
- DOI: 10.1136/bmj.a2812
Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial
Abstract
Objective: To determine the effectiveness of a single application of topical chloramphenicol ointment in preventing wound infection after minor dermatological surgery.
Design: Prospective randomised placebo controlled double blind multicentre trial.
Setting: Primary care in a regional centre in Queensland, Australia.
Participants: 972 minor surgery patients.
Interventions: A single topical dose of chloramphenicol (n=488) or paraffin ointment (n=484; placebo).
Main outcome measure: Incidence of infection.
Results: The incidence of infection in the chloramphenicol group (6.6%; 95% confidence interval 4.9 to 8.8) was significantly lower than that in the control group (11.0%; 7.9 to 15.1) (P=0.010). The absolute reduction in infection rate was 4.4%, the relative reduction was 40%, and the relative risk of wound infection in the control group was 1.7 (95% confidence interval 1.1 to 2.5) times higher than in the intervention group. The number needed to treat was 22.8.
Conclusion: Application of a single dose of topical chloramphenicol to high risk sutured wounds after minor surgery produces a moderate absolute reduction in infection rate that is statistically but not clinically significant. Trial registration Current Controlled Trials ISRCTN73223053.
Conflict of interest statement
Competing interests: None declared.
Figures
Comment in
- 
  
  Antibiotic prophylaxis for minor dermatological surgery in primary care.BMJ. 2009 Jan 15;338:a2749. doi: 10.1136/bmj.a2749. BMJ. 2009. PMID: 19147638 No abstract available.
- 
  
  Antibiotics for skin surgery. Preoperative integrity of skin surface predicts infection risk.BMJ. 2009 Feb 10;338:b516. doi: 10.1136/bmj.b516. BMJ. 2009. PMID: 19208704 No abstract available.
References
- 
    - Allen LV. Compounding gels. Secundum Artem. 2007;4(5) (available at www.picosearch.com/cgi-bin/ts.pl?index=406555&query=Gel&SEARCH=GO).
 
- 
    - Pfizer. Product information: Chloromycetin eye ointment. Pfizer, 2005. (available at www.pfizer.com.au/ProductInfo.aspx).
 
- 
    - Therapeutic guidelines: antibiotic. Version 13. North Melbourne, Victoria: Therapeutic Guidelines, 2006.
 
- 
    - Erel E, Platt A, Ramakrishnan V. Chloramphenicol use in plastic surgery. Br J Plast Surg 1999;52:326-7. - PubMed
 
- 
    - Pasapula C, Strick M. The use of chloramphenicol ointment as an adhesive for replacement of the nail bed after simple nail bed repairs. J Hand Surg (Br) 2004;29:634-5. - PubMed
 
Publication types
MeSH terms
Substances
Associated data
LinkOut - more resources
- Full Text Sources
- Medical
 
         
               
              